Complete Genomics and SOPHiA Genetics Join Forces to Deliver End‑to‑End Oncology Validation on MGI’s T1+ Sequencing Platform
Complete Genomics, the U.S. subsidiary of MGI Technologies (SHA: 688114), announced today a strategic collaboration...
Complete Genomics, the U.S. subsidiary of MGI Technologies (SHA: 688114), announced today a strategic collaboration...
Genesis Healthcare, a leading Japanese genetic‑testing provider, today announced the signing of a Memorandum of...
South Korean biotechnology firm JCBio and global genomics leader MGI Tech Co., Ltd. today signed...
China-based gene sequencing specialist MGI Tech Co., Ltd. announced a collaboration with Italy’s Negedia to...
China-based gene sequencing specialist MGI Tech Co., Ltd (SHA: 688114) announced that its latest mid-throughput...
China-based 3D Medicines (HKG: 1244) announced a strategic collaboration with domestic gene sequencing specialist MGI...
China-based gene sequencing specialist MGI Tech Co., Ltd. (SHA: 688114) has entered into a strategic...
Geneseeq Technology Inc., a genetic cancer testing service provider operating in Canada and China, has...
China-based gene sequencing specialist MGI Tech Co., Ltd (SHA: 688114) has partnered with OC Medicina...
China-based gene sequencing specialist MGI Tech Co., Ltd has announced that it has received a...
China-based gene sequencing specialist MGI Tech Co., Ltd (SHA: 688114) has entered into a strategic...
China-based gene sequencing specialist MGI Tech Co., Ltd has announced a collaboration with the Universidad...
China-based gene sequencing specialist, MGI Tech Co., Ltd, (SHA: 688114) has announced a commercial collaboration...
MGI Tech Co., Ltd., (SHA: 688114) a China-based leader in gene sequencing, announced a strategic...
MGI Tech Co., Ltd, a leading gene sequencing company based in China, has announced a...
MGI Tech Co., Ltd, a prominent gene sequencing company based in China, has disclosed a...
MGI Tech Co., Ltd, a leading gene sequencing specialist based in China, has entered into...
MGI Tech Co., Ltd, a leading gene sequencing specialist based in China, has announced a...
Kindstar Global (HKG: 9960), a biopharmaceutical company based in China, has announced a strategic partnership...
US legislators are working expeditiously to finalize the BioSecure Act, legislation that, if enacted, would...